Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19

被引:7
|
作者
Ramirez, Francisco E. [1 ]
Sanchez, Albert [1 ]
Pirskanen, Aki T. [2 ]
机构
[1] Weimar Inst, 20601 West Paoli Lane, Weimar, CA 95736 USA
[2] Terveysprojekti Karpalo Ry, Suonenjoki, Finland
关键词
Hydrotherapy; Therapeutic procedure; Immune response; Hydrothermotherapy; Fever; COVID-19; WHOLE-BODY HYPERTHERMIA; INVIVO HYPERTHERMIA; IMMUNE-RESPONSES; SAUNA; INFLAMMATION; FEVER; SARS; INTERLEUKIN-1; CORONAVIRUS; TEMPERATURE;
D O I
10.1016/j.mehy.2020.110363
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
COVID-19 is a new contagious disease caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a disease that has reached every continent in the world; it has overloaded the medical system worldwide and it has been declared a pandemic by the World Health Organization. Currently there is no definite treatment for COVID-19. We realize that host immunity is a critical factor in the outcome of coronavirus 2 infection. Here, however, we review the pathophysiology of the disease with a focus on searching for what we can do to combat this new disease. From this, we find that coronavirus is sensitive to heat. We have thus focused on this area of vulnerability of the virus. The emphasis of this hypothesis is on the action of body heat-internal (fever) and external (heat treatment)-in activating the immune system and its antiviral activities, and specifically related to the coronavirus. We hypothesize from this review that heat treatments has the potential to prevent COVID-19 and to decrease the severity of mild and moderate cases of Coronavirus. We propose heat treatments for this uncontrolled worldwide coronavirus pandemic while studies are being done to test the effectiveness of heat treatments in the prevention and treatment of COVID-19.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Neurological manifestations in mild and moderate cases of COVID-19
    Azim, Ghada Saed Abdel
    Osman, Marwa Abdellah
    [J]. EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01):
  • [2] Neurological manifestations in mild and moderate cases of COVID-19
    Ghada Saed Abdel Azim
    Marwa Abdellah Osman
    [J]. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [3] Mild or Moderate Covid-19
    Gandhi, Rajesh T.
    Lynch, John B.
    del Rio, Carlos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1757 - 1766
  • [4] Treatment of COVID-19 Patients with mild or moderate Disease
    Lichert, Frank
    [J]. PNEUMOLOGIE, 2021, 75 (03): : 174 - 174
  • [5] Thiol levels in mild or moderate COVID-19 patients: A comparison of variant and classic COVID-19 cases
    Dagcioglu, Basri Furkan
    Keskin, Ahmet
    Guner, Rahmet
    Kalem, Ayse Kaya
    Eser, Fatma
    Erel, Ozcan
    Neselioglu, Salim
    Bayrakdar, Fatma
    Ozkara, Adem
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (11)
  • [6] High prevalence of occult thrombosis in cases of mild/moderate COVID-19
    Chen, Budong
    Jiang, Chunguo
    Han, Bing
    Guan, Chunshuang
    Fang, Gaoli
    Yan, Shuo
    Wang, Kexin
    Liu, Ligai
    Conlon, Christopher P.
    Xie, Ruming
    Song, Rui
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 104 : 77 - 82
  • [7] Antivirals for the treatment of mild and moderate COVID-19 in South Africa
    Perumal, R.
    Naidoo, V.
    Govender, S.
    Gengiah, T. N.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2023, 113 (12): : 1535 - 1543
  • [8] Pharmacological Treatment of Patients with Mild to Moderate COVID-19: A Comprehensive Review
    Bestetti, Reinaldo B.
    Furlan-Daniel, Rosemary
    Silva, Vinicius M. R.
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (13)
  • [9] Azithromycin for mild-to-moderate COVID-19
    Patel, Jigar
    Berezowski, Ivan
    Abdelmonem, Ahmed
    Taylor, Dania
    Pourmand, Ali
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : E99 - E99
  • [10] Antibody dynamics and viral load in COVID-19: differences in mild, moderate and severe cases
    Ngoc, Kim
    Trifonova, Iva
    Christova, Iva
    Baymakova, Magdalena
    Gladnishka, Teodora
    Zasheva, Anelia
    Pishmisheva-Peleva, Maria
    Dragusheva, Elena
    Ivanova, Vladislava
    Plochev, Kamen
    Mihaylova-Garnizova, Raynichka
    [J]. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2023, 37 (01)